Zimmer Biomet Holdings, Inc. , a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket Approval Application (PMA) Supplement approval for the Oxford® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback